search
Back to results

An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall

Primary Purpose

Breast Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Stereoscopic Digital Mammography
Sponsored by
Emory University
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Breast Cancer focused on measuring Stereoscopic digital mammography, Breast cancer detection, Reduced rate of recall, Focal abnormalities detection

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Personal risk factors (any of the following) Personal history of breast and/or ovarian cancer, regardless of age. Prior breast biopsy that included any of the following high risk, benign lesion: Lobular carcinoma in-situ, Atypical ductal hyperplasia, Atypical lobular hyperplasia, Atypical columnar hyperplasia. Positive test for known mutations of BRCA 1 or 2 genes, regardless of age. History of chest irradiation for treatment of non-breast disease (EX:lymphoma, lung cancer) at least 15 years prior to enrollment. Family history (over 30 years of age with any of the following, some exceptions may appy) Ashkenazi Jewish ancestry, regardless of age. Any history of male breast cancer on the maternal or paternal side. Breast and ovarian cancer in a close relative (mother, sister, daughter) Breast or ovarian cancer in more than one close relative (mother,sister daughter) Breast cancer in a close relative (mother, sister, daughter) with early onset(<50 years of age) Breast and ovarian cancer in a 2nd. degree relative (grandmother, aunt, niece) with early onset of breast cancer. (<50 years of age) Multiple history of breast cancer in 1st. and 2nd. degree relatives. Exclusion Criteria: Patient does not meet any of the inclusion criteria, Patient has had breast augmentation, except for unilateral augmentation done for prior mastectomy, Patient has suspected or confirmed pregnancy, Patient has large breasts that cannot be adequately imaged on the 19 x 23 cm detector surface of the GE Senographe 2000D digital mammography unit.

Sites / Locations

  • Emory University Hospital

Outcomes

Primary Outcome Measures

sensitivity/specificity

Secondary Outcome Measures

Recall rate

Full Information

First Posted
September 13, 2005
Last Updated
November 19, 2013
Sponsor
Emory University
Collaborators
BBN Technologies
search

1. Study Identification

Unique Protocol Identification Number
NCT00208871
Brief Title
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
Official Title
An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
Study Type
Interventional

2. Study Status

Record Verification Date
November 2013
Overall Recruitment Status
Completed
Study Start Date
December 2004 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
March 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Emory University
Collaborators
BBN Technologies

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary goal of this study is to compare, within a clinical screening setting, the performance of stereoscopic digital mammography with standard (non-stereo) digital mammography in the detection of abnormalities in the breast, including early breast cancer.
Detailed Description
The clinical trial, begun in December, 2004, is being conducted at Emory University. Over the next three years, we will enroll and image about 2000 women who are at elevated risk for development of breast cancer (personal or family history of breast cancer) as they come in for their annual screening examinations. Each participating patient will be imaged with both systems, and the stereo and standard (non-stereo) images will be read independently by different mammographers. A stereoscopic digital mammogram consists of two x-ray images of the breast acquired from slightly different points of view on a digital mammography unit. The x-ray source is rotated 10-degrees between the two exposures while the position of the breast remains fixed in the compression device. The stereo pair of mammograms is viewed on a new third-generation, high-resolution stereo display workstation that was developed in the first part of this project. The mammographer views the stereo display wearing lightweight polarized glasses, enabling him or her to see in depth the internal structure within the breast. As a result, a subtle lesion that may be obscured by superimposed normal tissue in a standard 2D image, now becomes visible as the overlying and underlying normal tissue is separated in depth. Conversely, layers of tissue that may falsely resemble a lesion in a standard 2D image due to chance superimposition, are seen in the stereo mammogram to lie at different depths and, thus, will not be mistaken as a lesion. We anticipate that with stereo mammography the mammographers will detect subtle lesions in the stereo images that are missed in the non-stereo images. We also expect that there will be fewer false positive detections with the stereo images compared to the standard images. Finally, we also expect that the mammographers will be more confident in their judgments of what they see in the stereo images, resulting in a reduced rate of recall of patients for further work-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
Stereoscopic digital mammography, Breast cancer detection, Reduced rate of recall, Focal abnormalities detection

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1467 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Stereoscopic Digital Mammography
Intervention Description
screening digital 3D mammogram
Primary Outcome Measure Information:
Title
sensitivity/specificity
Time Frame
Aug '04 to Dec '07
Secondary Outcome Measure Information:
Title
Recall rate
Time Frame
Aug '04 to December '7

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Personal risk factors (any of the following) Personal history of breast and/or ovarian cancer, regardless of age. Prior breast biopsy that included any of the following high risk, benign lesion: Lobular carcinoma in-situ, Atypical ductal hyperplasia, Atypical lobular hyperplasia, Atypical columnar hyperplasia. Positive test for known mutations of BRCA 1 or 2 genes, regardless of age. History of chest irradiation for treatment of non-breast disease (EX:lymphoma, lung cancer) at least 15 years prior to enrollment. Family history (over 30 years of age with any of the following, some exceptions may appy) Ashkenazi Jewish ancestry, regardless of age. Any history of male breast cancer on the maternal or paternal side. Breast and ovarian cancer in a close relative (mother, sister, daughter) Breast or ovarian cancer in more than one close relative (mother,sister daughter) Breast cancer in a close relative (mother, sister, daughter) with early onset(<50 years of age) Breast and ovarian cancer in a 2nd. degree relative (grandmother, aunt, niece) with early onset of breast cancer. (<50 years of age) Multiple history of breast cancer in 1st. and 2nd. degree relatives. Exclusion Criteria: Patient does not meet any of the inclusion criteria, Patient has had breast augmentation, except for unilateral augmentation done for prior mastectomy, Patient has suspected or confirmed pregnancy, Patient has large breasts that cannot be adequately imaged on the 19 x 23 cm detector surface of the GE Senographe 2000D digital mammography unit.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David J Getty, Ph.D.
Organizational Affiliation
BBN Technologies
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Carl J D'Orsi, MD
Organizational Affiliation
Emory School of Medicine Site PI
Official's Role
Principal Investigator
Facility Information:
Facility Name
Emory University Hospital
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States

12. IPD Sharing Statement

Citations:
Citation
Getty DJ, Pickett RM, D'Orsi CJ. Stereoscopic digital mammography: improving detection and diagnosis of breast cancer. In: Computer Assisted Radiology and Surgery (CARS-2001). Berlin, Germany: Elsevier Science B.V., 2001.
Results Reference
background
Citation
Getty D. J. Stereoscopic digital mammography. Proceedings of the First Americas Display Engineering and Applications Conference (ADEAC '04), Ft. Worth, 2004, 11-14.
Results Reference
background
Citation
Getty, D. J. Stereoscopic and biplane digital radiography. In E. Samei & M. Flynn (Eds.), RSNA Categorical Course in Diagnostic Radiology Physics: Advances in Digital Radiography. RSNA Publications, 2003; 199-209.
Results Reference
background
Citation
Getty, D. J. Stereoscopic digital mammography: perceptual and display factors leading to improved early detection of breast cancer. In H-O Peitgen (Ed.), Digital Mammography, IWDM 2002, 6th International Workshop on Digital Mammography. Berlin: Springer, 2003, 431-435.
Results Reference
result
Links:
URL
http://www.cancer.emory.edu/
Description
clinical trials, stereoscopic digital mammography

Learn more about this trial

An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall

We'll reach out to this number within 24 hrs